Literature DB >> 22469055

Ionotropic glutamate receptor mRNA editing in the prefrontal cortex: no alterations in schizophrenia or bipolar disorder.

Rebecca Lyddon1, Scott Navarrett, Stella Dracheva.   

Abstract

BACKGROUND: Dysfunction of glutamate neurotransmission has been implicated in the pathology of schizophrenia and bipolar disorder, and one mechanism by which glutamate signalling can be altered is through RNA editing of ionotropic glutamate receptors (iGluRs). The objectives of the present study were to evaluate the editing status of iGluRs in the human prefrontal cortex, determine whether iGluR editing is associated with psychiatric disease or suicide and evaluate a potential association between editing and alternative splicing in the α-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) iGluR subunits' pre-mRNA.
METHODS: We studied specimens derived from patients with antemortem diagnoses of bipolar disorder (n = 31) or schizophrenia (n = 34) who died by suicide or other causes, and from psychiatrically healthy controls (n = 34) who died from causes other than suicide. The RNA editing at all 8 editing sites within AMPA (GluA2-4 subunits) and kainate (GluK1-2 subunits) iGluRs was analyzed using a novel real-time quantitative polymerase chain reaction assay.
RESULTS: No differences in editing were detected among schizophrenia, bipolar or control groups or between suicide completers and patients who died from causes other than suicide. The editing efficiency was significantly higher in the flop than in the flip splicoforms of GluA3-4 AMPA subunits (all p < 0.001). LIMITATIONS: The study is limited by the near absence of specimens from medicationnaive psychiatric patients and considerable variation in medication regimens among individuals, both of which introduce considerable uncertainty into the analysis of potential medication effects.
CONCLUSION: We found that iGluR RNA editing status was not associated with bipolar disorder, schizophrenia or suicide. Differences in editing between flip and flop splicoforms suggest that glutamate sensitivity of receptors containing GluA3 and/or GluA4 flop subunits is moderated as a result of increased editing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22469055      PMCID: PMC3380098          DOI: 10.1503/jpn.110107

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  42 in total

1.  Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2.

Authors:  M Higuchi; S Maas; F N Single; J Hartner; A Rozov; N Burnashev; D Feldmeyer; R Sprengel; P H Seeburg
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

2.  Regulation of kinetic properties of GluR2 AMPA receptor channels by alternative splicing.

Authors:  M Koike; S Tsukada; K Tsuzuki; H Kijima; S Ozawa
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

Review 3.  Sculpting AMPA receptor formation and function by alternative RNA processing.

Authors:  Andrew C Penn; Ingo H Greger
Journal:  RNA Biol       Date:  2009-11-18       Impact factor: 4.652

Review 4.  Glutamatergic theories of schizophrenia.

Authors:  Daniel C Javitt
Journal:  Isr J Psychiatry Relat Sci       Date:  2010       Impact factor: 0.481

5.  A new mode of corticothalamic transmission revealed in the Gria4(-/-) model of absence epilepsy.

Authors:  Jeanne T Paz; Astra S Bryant; Kathy Peng; Lief Fenno; Ofer Yizhar; Wayne N Frankel; Karl Deisseroth; John R Huguenard
Journal:  Nat Neurosci       Date:  2011-08-21       Impact factor: 24.884

Review 6.  Glutamatergic modulators: the future of treating mood disorders?

Authors:  Carlos Zarate; Rodrigo Machado-Vieira; Ioline Henter; Lobna Ibrahim; Nancy Diazgranados; Giacomo Salvadore
Journal:  Harv Rev Psychiatry       Date:  2010 Sep-Oct       Impact factor: 3.732

7.  Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2.

Authors:  Takuto Hideyama; Takenari Yamashita; Takeshi Suzuki; Shoji Tsuji; Miyoko Higuchi; Peter H Seeburg; Ryosuke Takahashi; Hidemi Misawa; Shin Kwak
Journal:  J Neurosci       Date:  2010-09-08       Impact factor: 6.167

8.  Comprehensive behavioural study of GluR4 knockout mice: implication in cognitive function.

Authors:  N Sagata; A Iwaki; T Aramaki; K Takao; S Kura; T Tsuzuki; R Kawakami; I Ito; T Kitamura; H Sugiyama; T Miyakawa; Y Fukumaki
Journal:  Genes Brain Behav       Date:  2010-11       Impact factor: 3.449

Review 9.  An update on the role of glutamate in the pathophysiology of depression.

Authors:  Nicholas D Mitchell; G B Baker
Journal:  Acta Psychiatr Scand       Date:  2010-01-25       Impact factor: 6.392

10.  Consistent levels of A-to-I RNA editing across individuals in coding sequences and non-conserved Alu repeats.

Authors:  Shoshana Greenberger; Erez Y Levanon; Nurit Paz-Yaacov; Aviv Barzilai; Michal Safran; Sivan Osenberg; Ninette Amariglio; Gideon Rechavi; Eli Eisenberg
Journal:  BMC Genomics       Date:  2010-10-28       Impact factor: 3.969

View more
  2 in total

1.  A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia.

Authors:  Mie Kubota-Sakashita; Kazuya Iwamoto; Miki Bundo; Tadafumi Kato
Journal:  Mol Brain       Date:  2014-01-21       Impact factor: 4.041

2.  The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment.

Authors:  Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro; Andrea de Bartolomeis
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.